Epigenetics in Drug Discovery
6
Jan
With the continuous development of pharmacogenetics and pharmacogenomics, people gradually found that individual differences in drug response genes can not be entirely explained by genetic polymorphisms. Chromatrap, a business unit of Porvair Sciences, has announced that it will be … Read More »